Prevalence of hepatitis B and C and risk factors for nonvaccination in inflammatory bowel disease patients in Northeast France
Inflammatory Bowel Diseases2009Vol. 16(6), pp. 916–924
Citations Over TimeTop 10% of 2009 papers
Jean‐Baptiste Chevaux, Abdelbasset Nani, Abderrahim Oussalah, Véronique Venard, Mouni Bensenane, Arthur Belle, Jean‐Louis Guéant, Marc‐André Bigard, Jean-Pierre Bronowicki, Laurent Peyrin‐Biroulet
Abstract
The prevalence of HBV and HCV infection in French IBD patients is similar to that of the general population. While the ECCO recommends an effective HBV vaccination in IBD, half of the patients were not vaccinated. The nonvaccination risk factors identified in our study may allow targeted vaccination coverage.
Related Papers
- → Seroprevalence of hepatitis B surface antigen (HBsAg) in Bo, Sierra Leone, 2012–2013(2018)18 cited
- → Immunity to hepatitis B vaccine among health care workers(2011)16 cited
- → Hepatitis B in Moroccan blood donors: a decade trend of the HBsAg prevalence in a resources limited country(2013)14 cited
- → False Positive Hepatitis B Surface Antigen Due to Recent Vaccination(2014)12 cited
- Hepatitis B surface antigen positive rate and risk factors analysis of primary and secondary students in Sunan province Yugu autonomous(2010)